Cargando…
First 1.5 years of pegvaliase clinic: Experiences and outcomes
We present Boston Children's Hospital's clinic model for pegvaliase therapy in adults with phenylketonuria (PKU) and clinical outcomes in 46 patients over the first 1.5 years of commercial therapy. Approximately 70% (18/26) of patients starting pegvaliase achieved blood phenylalanine (Phe)...
Autores principales: | Sacharow, Stephanie, Papaleo, Cassandra, Almeida, Kyla, Goodlett, Benjamin, Kritzer, Amy, Levy, Harvey, Martell, Leslie, Wessel, Ann, Viau, Krista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256053/ https://www.ncbi.nlm.nih.gov/pubmed/32489881 http://dx.doi.org/10.1016/j.ymgmr.2020.100603 |
Ejemplares similares
-
Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
por: Viau, Krista, et al.
Publicado: (2023) -
Reinstitution of pegvaliase therapy during lactation
por: Rohr, Frances, et al.
Publicado: (2022) -
Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report
por: Rohr, Fran, et al.
Publicado: (2020) -
Evidence- and consensus-based recommendations for the use of
pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018) -
Successful desensitization of Pegvaliase (Palynziq®) in a patient with phenylketonuria
por: Patrawala, Meera, et al.
Publicado: (2020)